Decreased dopamine transporter availability in male smokers — A dual isotope SPECT study

INTRODUCTION Although the mesolimbic dopaminergic system has been shown to play a role in reinforcing tobacco smoking, results of imaging studies that examine the relationship between tobacco smoking and the central dopamine system remain discrepant. To delineate the role of tobacco addiction in central pre- and post-synaptic dopaminergic activities, we analyzed the central D2-family receptors, the dopamine transporters (DAT), and degrees of dependence in male smokers. METHODS Eleven male smokers and 11 healthy non-smokers were recruited. The striatal dopamine D2/D3 receptor availability was approximated using SPECT and [123 I] IBZM while the DAT availability was approximated using SPECT and [99m Tc] TRODAT-1. All of the smokers completed the Fagerström Test for Nicotine Dependence (FTND) and other related questionnaires. RESULTS A decrease in DAT availability in the striatum of male smokers is noted (p<05). However, the striatal D2/D3 receptor availability in male smokers does not differ from that of non-smokers. CONCLUSIONS These findings suggest that cigarette smoking may alter central dopamine functions in males, particularly at the pre-synaptic sites.

[1]  C. Pomerleau,et al.  Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. , 1995, Journal of substance abuse.

[2]  Christian la Fougere,et al.  The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder , 2003, Neuroscience & Biobehavioral Reviews.

[3]  H. Kung,et al.  Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Edythe D London,et al.  PET studies of the influences of nicotine on neural systems in cigarette smokers. , 2003, The American journal of psychiatry.

[5]  N. Volkow,et al.  INAUGURAL ARTICLES: Low monoamine oxidase B in peripheral organs in smokers , 2003 .

[6]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[7]  R G Hoffmann,et al.  Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. , 1998, The American journal of psychiatry.

[8]  S. Hersch,et al.  The dopamine transporter: immunochemical characterization and localization in brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  G. Uhl,et al.  Dopamine transporter immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[10]  A. Brody Functional brain imaging of tobacco use and dependence. , 2006, Journal of psychiatric research.

[11]  Jeffrey H. Meyer,et al.  Smoking-induced ventral striatum dopamine release. , 2004, The American journal of psychiatry.

[12]  Klaus Tatsch,et al.  Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. , 2002, The international journal of neuropsychopharmacology.

[13]  S. Woods,et al.  Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  R. Klesges,et al.  A study of the psychometric and predictive properties of the Fagerström Test for Nicotine Dependence in a population of young smokers. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[15]  M. Laruelle Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  A. Joyce,et al.  Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. , 2001, The Journal of pharmacology and experimental therapeutics.

[17]  E. Levin,et al.  Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia , 2003, Schizophrenia Research.

[18]  Caryn Lerman,et al.  Dopamine Transporter Binding in Smokers and Nonsmokers , 2007, Clinical nuclear medicine.

[19]  I. Sora,et al.  Cocaine, reward, movement and monoamine transporters , 2002, Molecular Psychiatry.

[20]  Y. Nishiyama,et al.  A study of the acute effect of smoking on cerebral blood flow using 99mTc-ECD SPET , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  T. Svensson,et al.  Nicotine dependence, midbrain dopamine systems and psychiatric disorders. , 1995, Pharmacology & toxicology.

[22]  P S Goldman-Rakic,et al.  Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A genetic association for cigarette smoking behavior. , 1999 .

[24]  P. Chen,et al.  Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. , 2004, The American journal of psychiatry.

[25]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[26]  P. Piccini Dopamine transporter: Basic aspects and neuroimaging , 2003, Movement disorders : official journal of the Movement Disorder Society.

[27]  E. Bowman,et al.  Evidence suggesting the role of specific genetic factors in cigarette smoking. , 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[28]  G. Chiara,et al.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs , 1996, Nature.

[29]  L. Iversen ... harmful to the brain , 1996, Nature.

[30]  J. Hietala,et al.  High levels of dopamine activity in the basal ganglia of cigarette smokers. , 2000, The American journal of psychiatry.

[31]  J. Jolles,et al.  Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). , 2003, Neuropediatrics.

[32]  W. Hwang,et al.  Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  J D Brodie,et al.  A pharmacologic strategy for the treatment of nicotine addiction , 1999, Synapse.

[34]  L. Kozlowski,et al.  Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. , 1994, Drug and alcohol dependence.

[35]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[36]  S. Hersch,et al.  Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra , 1997, The Journal of comparative neurology.

[37]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[38]  Alain Dagher,et al.  The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride , 2004, Synapse.

[39]  N. Volkow,et al.  Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  N. Volkow,et al.  Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.

[41]  J. McEvoy,et al.  Striatal dopamine D2/D3 receptor availability in male smokers , 2006, Psychiatry Research: Neuroimaging.

[42]  E. Perry,et al.  Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use , 1998, Neuroscience.

[43]  Klaus Tatsch,et al.  Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography , 2000, Neuroscience Letters.